Oncology Central

An update on anti-EGF receptor therapy and the move towards targeted therapy and precision medicine


Dr Marwan Fakih* speaks to Roshaine Gunawardana, Managing Commissioning Editor: Marwan Fakih is a Professor at the City of Hope Comprehensive Cancer Center where he serves as the Section Head for Gastrointestinal Oncology. Dr Fakih’s research interest is in experimental therapeutics, particularly in what pertains to the field of metastatic colorectal cancer. His current clinical research is focusing on developing more effective therapies for patients with RAS-wild type tumors with EGF receptor resistance and on investigating MEK inhibitors in the treatment of metastatic colorectal cancer.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.